Plato Investment Management Ltd lessened its holdings in Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO) by 30.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 14,316 shares of the basic materials company’s stock after selling 6,287 shares during the period. Plato Investment Management Ltd’s holdings in Cameco were worth $1,319,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Cameco by 79.4% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 249,992 shares of the basic materials company’s stock valued at $20,964,000 after buying an additional 110,629 shares during the period. NWF Advisory Services Inc. purchased a new position in Cameco in the 3rd quarter worth approximately $1,996,000. Thames Capital Management LLC boosted its holdings in Cameco by 66.8% in the 3rd quarter. Thames Capital Management LLC now owns 107,062 shares of the basic materials company’s stock worth $8,978,000 after acquiring an additional 42,879 shares during the period. Massachusetts Financial Services Co. MA grew its position in Cameco by 7.9% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,755,802 shares of the basic materials company’s stock valued at $231,102,000 after acquiring an additional 202,279 shares in the last quarter. Finally, Mediolanum International Funds Ltd raised its stake in shares of Cameco by 165.5% during the third quarter. Mediolanum International Funds Ltd now owns 34,267 shares of the basic materials company’s stock valued at $2,894,000 after purchasing an additional 21,361 shares during the period. 70.21% of the stock is owned by hedge funds and other institutional investors.
Cameco Stock Performance
Cameco stock opened at $116.79 on Monday. Cameco Corporation has a 52 week low of $48.81 and a 52 week high of $135.24. The company has a current ratio of 3.08, a quick ratio of 2.09 and a debt-to-equity ratio of 0.14. The stock has a market cap of $50.87 billion, a P/E ratio of 108.14, a price-to-earnings-growth ratio of 2.11 and a beta of 1.04. The stock has a 50 day moving average of $114.87 and a 200-day moving average of $105.97.
Cameco News Summary
Here are the key news stories impacting Cameco this week:
- Positive Sentiment: Scotiabank raised its FY2026 earnings estimate for Cameco to $1.07 per share from $0.89 and maintained an Outperform rating with a $175 price target, signaling continued confidence in the company’s longer-term earnings power.
- Neutral Sentiment: Unusual options activity showed heavy call buying in Cameco, with 384,705 call contracts purchased versus the typical 24,198, suggesting traders are positioning for more upside or volatility.
- Neutral Sentiment: Cameco announced the election of nine board members at its annual meeting, a routine governance update that is unlikely to materially affect fundamentals on its own. Cameco Announces Election of Directors
- Neutral Sentiment: Scotiabank also trimmed its FY2027 earnings estimate to $1.37 from $1.47, which softens the bullish tone a bit, though the firm still sees Cameco as an outperformer.
- Negative Sentiment: Cameco shares were pressured along with other nuclear names after a strong recent rally, as investors took profits following the sector’s explosive run-up. NANO Nuclear Slides 10%, Oklo Falls 8%, Cameco Slips 4% After Nuclear Stocks Explosive Rally
Wall Street Analyst Weigh In
A number of research analysts have recently commented on the stock. Scotiabank reissued an “outperform” rating and set a $175.00 target price on shares of Cameco in a research report on Wednesday. Zacks Research lowered shares of Cameco from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 18th. Canadian Imperial Bank of Commerce boosted their price objective on shares of Cameco to $202.00 in a report on Monday, March 9th. Weiss Ratings cut shares of Cameco from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday. Finally, William Blair started coverage on Cameco in a research note on Monday, April 20th. They set an “outperform” rating for the company. Eleven analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $153.13.
Check Out Our Latest Report on CCJ
Cameco Company Profile
Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long?term and spot contracts.
The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.
Featured Articles
- Five stocks we like better than Cameco
- Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum
- Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players
- Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery
- 3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.
